Cargando…
LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis
BACKGROUND: Bladder cancer is one of the most common urinary malignancies, and has a high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic biomarkers for bladder cancer, we conducted a meta-analysis to analyze the association between long non-coding RNA (lncRNA...
Autores principales: | Quan, Jing, Pan, Xiang, Zhao, Liwen, Li, Zuwei, Dai, Kangfu, Yan, Fangli, Liu, Suyue, Ma, Hongfei, Lai, Yongqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177400/ https://www.ncbi.nlm.nih.gov/pubmed/30323619 http://dx.doi.org/10.2147/OTT.S167853 |
Ejemplares similares
-
lncRNAs as potential molecular biomarkers in the clinicopathology and prognosis of cholangiocarcinoma: a systematic review and meta-analysis
por: Dai, Kangfu, et al.
Publicado: (2019) -
m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer
por: Li, Zuwei, et al.
Publicado: (2021) -
LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer
por: Dong, Lujia, et al.
Publicado: (2022) -
The value of urinary exosomal lncRNA SNHG16 as a diagnostic biomarker for bladder cancer
por: Liu, Chengyi, et al.
Publicado: (2023) -
Construction of an lncRNA model for prognostic prediction of bladder cancer
por: Shi, Changlong, et al.
Publicado: (2022)